NM_004360.5(CDH1):c.1340_1346del (p.Lys447fs) AND Hereditary diffuse gastric adenocarcinoma

Germline classification:: Pathogenic (1 submission)
Last evaluated:: Sep 7, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003454369.1

Allele description [Variation Report for NM_004360.5(CDH1):c.1340_1346del (p.Lys447fs)]

NM_004360.5(CDH1):c.1340_1346del (p.Lys447fs)

Gene:

CDH1:cadherin 1 [Gene - OMIM - HGNC]

Variant type:

Deletion

Cytogenetic location:

16q22.1

Genomic location:

Preferred name:

NM_004360.5(CDH1):c.1340_1346del (p.Lys447fs)

HGVS:

NC_000016.10:g.68815534_68815540del
NG_008021.1:g.83243_83249del
NM_001317184.2:c.1157_1163del
NM_001317185.2:c.-209_-203del
NM_001317186.2:c.-480_-474del
NM_004360.5:c.1340_1346delMANE SELECT
NP_001304113.1:p.Lys386fs
NP_004351.1:p.Lys447Serfs
NP_004351.1:p.Lys447fs
LRG_301t1:c.1340_1346del
LRG_301:g.83243_83249del
LRG_301p1:p.Lys447Serfs
NC_000016.9:g.68849437_68849443del
NM_004360.3:c.1340_1346delAGCAGCA

Protein change:

K386fs

Links:

dbSNP: rs2543930246

NCBI 1000 Genomes Browser:

rs2543930246

Molecular consequence:

NM_001317185.2:c.-209_-203del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001317186.2:c.-480_-474del - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001317184.2:c.1157_1163del - frameshift variant - [Sequence Ontology: SO:0001589]
NM_004360.5:c.1340_1346del - frameshift variant - [Sequence Ontology: SO:0001589]

Condition(s)

Name:: Hereditary diffuse gastric adenocarcinoma (HDGC)
Synonyms:: DIFFUSE GASTRIC AND LOBULAR BREAST CANCER SYNDROME
Identifiers:: MONDO: MONDO:0007648; MedGen: C1708349; Orphanet: 26106; OMIM: 137215

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004186632	Myriad Genetics, Inc.	criteria provided, single submitter (Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))	Pathogenic (Sep 7, 2023)	unknown	clinical testing	Citation Link

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004186632

Myriad Genetics, Inc.

criteria provided, single submitter

(Myriad Autosomal Dominant, Autosomal Recessive and X-Linked Classification Criteria (2023))

Pathogenic
(Sep 7, 2023)

unknown

clinical testing

Citation Link

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	unknown	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Details of each submission

From Myriad Genetics, Inc., SCV004186632.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	not provided

Description

This variant is considered pathogenic. This variant creates a frameshift predicted to result in premature protein truncation.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	unknown	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: May 16, 2025

ClinVar

Relating variation to medicine